» Articles » PMID: 21541749

Combining Molecular Dynamics and Docking Simulations of the Cytidine Deaminase from Mycobacterium Tuberculosis H37Rv

Overview
Journal J Mol Model
Publisher Springer
Specialty Molecular Biology
Date 2011 May 5
PMID 21541749
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Cytidine Deaminase (CD) is an evolutionarily conserved enzyme that participates in the pyrimidine salvage pathway recycling cytidine and deoxycytidine into uridine and deoxyuridine, respectively. Here, our goal is to apply computational techniques in the pursuit of potential inhibitors of Mycobacterium tuberculosis CD (MtCDA) enzyme activity. Molecular docking simulation was applied to find the possible hit compounds. Molecular dynamics simulations were also carried out to investigate the physically relevant motions involved in the protein-ligand recognition process, aiming at providing estimates for free energy of binding. The proposed approach was capable of identifying a potential inhibitor, which was experimentally confirmed by IC(50) evaluation. Our findings open up the possibility to extend this protocol to different databases in order to find new potential inhibitors for promising targets based on a rational drug design process.

Citing Articles

Fusing a carbohydrate-binding module into the Aspergillus usamii β-mannanase to improve its thermostability and cellulose-binding capacity by in silico design.

Tang C, Li J, Wei X, Min R, Gao S, Wang J PLoS One. 2013; 8(5):e64766.

PMID: 23741390 PMC: 3669383. DOI: 10.1371/journal.pone.0064766.

References
1.
van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark A, Berendsen H . GROMACS: fast, flexible, and free. J Comput Chem. 2005; 26(16):1701-18. DOI: 10.1002/jcc.20291. View

2.
Johansson E, Mejlhede N, Neuhard J, Larsen S . Crystal structure of the tetrameric cytidine deaminase from Bacillus subtilis at 2.0 A resolution. Biochemistry. 2002; 41(8):2563-70. DOI: 10.1021/bi011849a. View

3.
Irwin J, Shoichet B . ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005; 45(1):177-82. PMC: 1360656. DOI: 10.1021/ci049714+. View

4.
Wheeler P . Biosynthesis and scavenging of pyrimidines by pathogenic mycobacteria. J Gen Microbiol. 1990; 136(1):189-201. DOI: 10.1099/00221287-136-1-189. View

5.
Hyde J . Targeting purine and pyrimidine metabolism in human apicomplexan parasites. Curr Drug Targets. 2007; 8(1):31-47. PMC: 2720675. DOI: 10.2174/138945007779315524. View